The global Hepatitis E Diagnostic Tests Market is experiencing gradual growth as awareness of hepatitis E increases and healthcare systems place greater emphasis on infectious disease screening, early diagnosis, and disease surveillance. Diagnostic testing plays an important role in identifying hepatitis E infections and supporting appropriate patient management.

According to Fortune Business Insights, the global Hepatitis E Diagnostic Tests Market size was valued at USD 60.70 million in 2025. The market is projected to grow from USD 63.65 million in 2026 to USD 93.08 million by 2034, exhibiting a CAGR of 4.87% during the forecast period.

Why is the Hepatitis E Diagnostic Tests Market Growing?

Increasing awareness regarding viral hepatitis and the importance of early diagnosis is supporting market expansion. Hepatitis E is commonly associated with contaminated water and food, making diagnostic testing particularly important in regions where sanitation and water quality remain concerns.

Healthcare providers, diagnostic laboratories, hospitals, blood banks, and public health institutions are increasing their focus on accurate hepatitis screening.

Hepatitis E diagnostic tests are used in:

• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Public Health Centers
• Infectious Disease Screening
• Clinical Research
• Disease Surveillance
• Outbreak Monitoring

Increasing healthcare investments and improvements in laboratory infrastructure are expected to create further opportunities for diagnostic test manufacturers.

Key Market Trends Shaping Industry Growth

Increasing Adoption of Automated Testing

Healthcare laboratories are increasingly adopting automated immunoassay platforms to improve testing efficiency and handle larger sample volumes.

Automation can reduce manual processes and support consistent testing workflows, making it increasingly relevant for hospitals and diagnostic centers.

Growth of Rapid Diagnostic Testing